SOCS2 and neoplasm: SOCS2 limits adaptive antitumor immunity and DC‐based priming of T cells in vivo.49 These results link immune homeostasis to key determinants of antitumor immunity and escape, uncovering the underlying mechanism by which IFNγ contributes to tumor escape in the tumor microenvironments.